Identifying Novel Therapeutics And Modifiers Of Myotonic Dystrophy Type 1Jesús Frías(Baylor College of Medicine)UnknownMay 1, 202410.54014/ary6-q838Cited by 0SaveCiteExport RISWatch citationsRelated PapersRapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR|Nature Biotechnology|2022|45